Weight Loss Pills Are On The Horizon
Sept. 23, 2025 Soon, there may be a promising alternative for the needle-averse, as results of a recent Phase 3 trial confirmed that a daily
Pfizer to Buy Weight-Loss Drug Developer Metsera
Sept. 23, 2025 Pfizer has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera in a deal that provides a re-entry for
Keto Diet Is On The Decline
Sept. 12, 2025 According to an article by Food Navigator, the ketogenic diet, popular since the 1990s, is in decline, faced by consumer fatigue over
FDA Tightens Oversight of GLP-1 Ingredients Imports
Sept. 9, 2025 According to Reuters, “The U.S. Food and Drug Administration is tightening oversight of imports of GLP-1 drug ingredients, used for weight loss
Queen Latifah To Pitch New Weight Watchers Menopause Program
Sept. 8, 2025 WW today announced the launch of Weight Watchers for Menopause, a program that is designed to support women through every stage of
Weight Watchers Hires New International V.P.
Sept. 3, 2025 WW announced the appointment of Alejandro Bethlen as Executive Vice President, International, effective immediately. In this role, Bethlen will oversee WeightWatchers’ business
Weight Watchers Reports Q2 2025 Results
August 11, 2025 The company emerged from its financial reorganization process on June 24, 2025. According to Tara Comonte, CEO of Weight Watchers: “This marks
Novo Nordisk Obesity Drugs Sales Slow – Compounders Still Selling illegally
August 6, 2025 Sales of Novo Nordisk’s injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and the threat of U.S. tariffs, coupled